- Investing Ideas
- Global Pharmaceuticals & Biotech Spotless Management
Global Pharmaceuticals & Biotech Spotless Management
Results
7
Well rounded companies, with acceptable leverage, projected to deliver an ROE north of 20% in three years.
7 companies
AstraZeneca
Market Cap: UK£222.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN
UK£142.40
7D
2.8%
1Y
37.4%
Gilead Sciences
Market Cap: US$169.3b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GILD
US$135.82
7D
7.8%
1Y
19.9%
Chugai Pharmaceutical
Market Cap: JP¥12.1t
Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.
4519
JP¥7,345.00
7D
0.9%
1Y
7.9%
Orion Oyj
Market Cap: €10.1b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€70.70
7D
-0.1%
1Y
7.7%
Shanghai Allist Pharmaceuticals
Market Cap: CN¥53.3b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥118.53
7D
-5.8%
1Y
27.6%
Xiamen Amoytop Biotech
Market Cap: CN¥22.3b
Engages in research, development, production, and sale of recombinant protein drugs in China and internationally.
688278
CN¥54.60
7D
-4.9%
1Y
-21.9%
PharmaResearch
Market Cap: ₩3.4t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩327,000.00
7D
-10.8%
1Y
-44.9%